Jackie Knee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jackie Knee has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
- Oliver Cumming
London School of Hygiene & Tropical Medicine
22 shared publications - Joe Brown
University of North Carolina at Chapel Hill
20 shared publications - Drew Capone
Affiliation Department of Environmental and Occupational Health, School of Public Health-Bloomington, Indiana University, Bloomington, Indiana, United States of America
15 shared publications Rassul Nalá
Instituto Nacional de Saúde (Mozambique), Maputo, Mozambique
14 shared publications- David Holcomb
University of North Carolina at Chapel Hill
12 shared publications Oliver Cumming
London School of Hygiene and Tropical Medicine
12 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Public Library of Science (PLoS) in PLOS Water
- Vol. 5 (10) , e0000646
Pragmatic water and health research in a complex emergency: Learnings and way forward
Climate change is straining water and sanitation services (WSS), leading to disruptions that threaten public health. In low-income and fragile contexts, there is an urgent need to increase investments in WSS, as well as to enhance efficiency in the utilisation of available financial resources. Operational research can help optimise future investments in WSS. In this perspective, we share our experience carrying out research embedded within a large-scale water supply infrastructure improvement programme in an urban, cholera-endemic area in South Kivu (Democratic Republic of the Congo). Through the lens of this concrete example, we highlight the need for rigorous research on higher quality drinking water services in low-income and fragile countries, discuss how multi-stakeholder research partnerships and pragmatic methods can contribute to the generation of rigorous evidence where it is most needed, and illustrate the role of research in strengthening capacities for both science and practice.
- 8 October 2026
- Published by Public Library of Science (PLoS) in PLOS Water
- Vol. 5 (10) , e0000646
Open AccessPragmatic water and health research in a complex emergency: Learnings and way forward
Climate change is straining water and sanitation services (WSS), leading to disruptions that threaten public health. In low-income and fragile contexts, there is an urgent need to increase investments in WSS, as well as to enhance efficiency in the utilisation of available financial resources. Operational research can help optimise future investments in WSS. In this perspective, we share our experience carrying out research embedded within a large-scale water supply infrastructure improvement programme in an urban, cholera-endemic area in South Kivu (Democratic Republic of the Congo). Through the lens of this concrete example, we highlight the need for rigorous research on higher quality drinking water services in low-income and fragile countries, discuss how multi-stakeholder research partnerships and pragmatic methods can contribute to the generation of rigorous evidence where it is most needed, and illustrate the role of research in strengthening capacities for both science and practice.
- Open Access
Impact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis
Background: Oral cholera vaccines (OCVs) are a key component of cholera control recommended in cholera-endemic areas. Yet evidence of their population-level impact is limited, especially in Africa where most cholera deaths occur. Here, we estimate the impact of mass administration of OCVs in the cholera-endemic city of Uvira, Democratic Republic of the Congo. Methods: We conducted enhanced cholera surveillance at the two official cholera treatment facilities in Uvira between Jan 2017 and Dec 2023, centered around a mass vaccination campaign that achieved 66% coverage with at least one dose of Euvichol Plus vaccine in 2020. We combined systematic rapid diagnostic case testing with repeated, representative population surveys capturing healthcare-seeking behavior, vaccination, population mobility, and antibody profiles to estimate seroincidence. We developed a Bayesian framework that integrates these data into an ensemble of mechanistic cholera transmission models that account for time-varying transmissibility, realistic immunity dynamics and loss of vaccination coverage to population turnover. OCV impact was assessed through ensemble counterfactual modeling of alternative vaccination scenarios. Findings: We estimate that the 2020 mass vaccination averted 56% (95% Credible Interval: 34-81) of infections and deaths over the subsequent three years. This corresponds to 2,350 (median, 95% CrI: 890-8,960) averted facility-attended cases, and 44 (median, 95% CrI: 16-150) averted facility and community deaths. Vaccination of all of Uvira’s eligible population would have averted 64% (median, 95% CrI: 43-87) of cases and deaths, with a negative but limited influence of vaccine coverage loss because of population turnover (71% median, 95% CrI: 52-90 at half the population turnover). Interpretation: Although mass vaccination averted a significant fraction of cholera cases that would have otherwise occurred in this endemic setting, imperfect coverage, population turnover, and high transmission rates contributed in offsetting the larger potential benefits of OCV. Successful cholera control in Uvira hinges on multisectorial approaches including provision of safe water and sanitation. Setting and communicating realistic expectations for mass vaccination programs in highly endemic areas is critical for maintaining confidence in the current generation of OCVs. Funding: Gavi (M&E 9166 09 20 A16) and the Wellcome Trust (221688/Z/20/Z). Research in Context: Evidence before this study: We searched PubMed for studies published between January 1, 2000 and June 2026 using the terms (“oral cholera vaccine” OR “OCV”) AND (“vaccine effectiveness” OR “vaccine impact” OR “indirect protection” OR “herd immunity” OR “population-level protection”). We also reviewed World Health Organisation (WHO) position papers and reports from the Global Task Force on Cholera Control (GTFCC). Inactivated oral cholera vaccines provide strong direct protection against symptomatic cholera, with randomized controlled trials and observational studies reporting effectiveness estimates typically exceeding 50% in the first three years after vaccination. In a previous study we showed that one-dose vaccine effectiveness was 52% 12-17 months after vaccination in Uvira, DRC. However, evidence on the population-level impact of preventive mass vaccination campaigns, which encompasses both direct and indirect protection, is thin. The only published estimates from clinical trials, both conducted in South Asia, reported overall protection of 37% over a 2-year period in Dhaka, Bangladesh and 75% over a 3-year period in Kolkata, India. No rigorous real-world estimates of mass OCV impact have been published from sub-Saharan Africa, where the vast majority of global cholera deaths occur. A major obstacle behind this gap is the lack of high-quality pre- and post-vaccination surveillance to support robust estimation of impact. The WHO and GTFCC have identified this evidence gap as a major research priority. Added value of this study: To our knowledge, this is the first study to provide a rigorous, data-driven estimate of the population-level impact of a preventive mass OCV campaign in a cholera-endemic African setting. Drawing on 7 years of enhanced clinical surveillance, three population-representative household surveys measuring vaccine coverage, population mobility and health-care seeking behaviors, a serological survey, and a novel ensemble of compartmental transmission models, we estimated that the 2020 campaign in Uvira, DRC — which achieved approximately 66% coverage of at least one dose of Euvichol Plus vaccine — averted 56% (95% CrI: 34-81) of cholera cases and deaths over the subsequent three years. This corresponds to 2,350 (median, 95% CrI: 890-8,960) averted cases that would have sought care at official cholera treatment facilities, and 44 (median, 95% CrI: 16-150) averted deaths. Our transmission modeling framework also yielded new insights into cholera natural history in this endemic setting: symptomatic infection conferred strong and durable immunity (mean duration 6 years), while immunity following asymptomatic infection was substantially weaker. We further quantify how vaccination coverage and population turnover jointly determine vaccination program impact, providing a practical framework for informing future campaign design. Implications of all the available evidence: Taken together with prior evidence from South Asia, our findings indicate that preventive mass OCV campaigns can avert a substantial fraction of cholera cases and deaths in highly endemic settings across different epidemiological contexts. Nonetheless, the resurgence of cholera a year after the vaccination campaign underscores that OCV campaigns alone are insufficient for sustained cholera control in similar settings due to high transmission rates and high population...
Open AccessImpact of mass oral cholera vaccination in an endemic area of the Democratic Republic of the Congo: a surveillance-based counterfactual modeling analysis
Background: Oral cholera vaccines (OCVs) are a key component of cholera control recommended in cholera-endemic areas. Yet evidence of their population-level impact is limited, especially in Africa where most cholera deaths occur. Here, we estimate the impact of mass administration of OCVs in the cholera-endemic city of Uvira, Democratic Republic of the Congo. Methods: We conducted enhanced cholera surveillance at the two official cholera treatment facilities in Uvira between Jan 2017 and Dec 2023, centered around a mass vaccination campaign that achieved 66% coverage with at least one dose of Euvichol Plus vaccine in 2020. We combined systematic rapid diagnostic case testing with repeated, representative population surveys capturing healthcare-seeking behavior, vaccination, population mobility, and antibody profiles to estimate seroincidence. We developed a Bayesian framework that integrates these data into an ensemble of mechanistic cholera transmission models that account for time-varying transmissibility, realistic immunity dynamics and loss of vaccination coverage to population turnover. OCV impact was assessed through ensemble counterfactual modeling of alternative vaccination scenarios. Findings: We estimate that the 2020 mass vaccination averted 56% (95% Credible Interval: 34-81) of infections and deaths over the subsequent three years. This corresponds to 2,350 (median, 95% CrI: 890-8,960) averted facility-attended cases, and 44 (median, 95% CrI: 16-150) averted facility and community deaths. Vaccination of all of Uvira’s eligible population would have averted 64% (median, 95% CrI: 43-87) of cases and deaths, with a negative but limited influence of vaccine coverage loss because of population turnover (71% median, 95% CrI: 52-90 at half the population turnover). Interpretation: Although mass vaccination averted a significant fraction of cholera cases that would have otherwise occurred in this endemic setting, imperfect coverage, population turnover, and high transmission rates contributed in offsetting the larger potential benefits of OCV. Successful cholera control in Uvira hinges on multisectorial approaches including provision of safe water and sanitation. Setting and communicating realistic expectations for mass vaccination programs in highly endemic areas is critical for maintaining confidence in the current generation of OCVs. Funding: Gavi (M&E 9166 09 20 A16) and the Wellcome Trust (221688/Z/20/Z). Research in Context: Evidence before this study: We searched PubMed for studies published between January 1, 2000 and June 2026 using the terms (“oral cholera vaccine” OR “OCV”) AND (“vaccine effectiveness” OR “vaccine impact” OR “indirect protection” OR “herd immunity” OR “population-level protection”). We also reviewed World Health Organisation (WHO) position papers and reports from the Global Task Force on Cholera Control (GTFCC). Inactivated oral cholera vaccines provide strong direct protection against symptomatic cholera, with randomized controlled trials and observational studies reporting effectiveness estimates typically exceeding 50% in the first three years after vaccination. In a previous study we showed that one-dose vaccine effectiveness was 52% 12-17 months after vaccination in Uvira, DRC. However, evidence on the population-level impact of preventive mass vaccination campaigns, which encompasses both direct and indirect protection, is thin. The only published estimates from clinical trials, both conducted in South Asia, reported overall protection of 37% over a 2-year period in Dhaka, Bangladesh and 75% over a 3-year period in Kolkata, India. No rigorous real-world estimates of mass OCV impact have been published from sub-Saharan Africa, where the vast majority of global cholera deaths occur. A major obstacle behind this gap is the lack of high-quality pre- and post-vaccination surveillance to support robust estimation of impact. The WHO and GTFCC have identified this evidence gap as a major research priority. Added value of this study: To our knowledge, this is the first study to provide a rigorous, data-driven estimate of the population-level impact of a preventive mass OCV campaign in a cholera-endemic African setting. Drawing on 7 years of enhanced clinical surveillance, three population-representative household surveys measuring vaccine coverage, population mobility and health-care seeking behaviors, a serological survey, and a novel ensemble of compartmental transmission models, we estimated that the 2020 campaign in Uvira, DRC — which achieved approximately 66% coverage of at least one dose of Euvichol Plus vaccine — averted 56% (95% CrI: 34-81) of cholera cases and deaths over the subsequent three years. This corresponds to 2,350 (median, 95% CrI: 890-8,960) averted cases that would have sought care at official cholera treatment facilities, and 44 (median, 95% CrI: 16-150) averted deaths. Our transmission modeling framework also yielded new insights into cholera natural history in this endemic setting: symptomatic infection conferred strong and durable immunity (mean duration 6 years), while immunity following asymptomatic infection was substantially weaker. We further quantify how vaccination coverage and population turnover jointly determine vaccination program impact, providing a practical framework for informing future campaign design. Implications of all the available evidence: Taken together with prior evidence from South Asia, our findings indicate that preventive mass OCV campaigns can avert a substantial fraction of cholera cases and deaths in highly endemic settings across different epidemiological contexts. Nonetheless, the resurgence of cholera a year after the vaccination campaign underscores that OCV campaigns alone are insufficient for sustained cholera control in similar settings due to high transmission rates and high population...
- Open Access
Effect of household water treatment and hygiene promotion integration on outpatient treatment for severe acute malnutrition in Senegal: the TISA cluster-randomised controlled trial
Background: Severe acute malnutrition (SAM) affects approximately 12 million children globally. The aim of this study was to assess the effectiveness of integrating a household water treatment and hygiene promotion intervention within the national protocol of Senegal for outpatient treatment of children aged 6-59 months of age with uncomplicated SAM. Methods: This was a pragmatic cluster-randomised controlled trial with health centres allocated 1:1 to receive either the standard protocol alone or the standard protocol with the addition of the water treatment and hygiene intervention. The primary outcome of the trial was SAM recovery defined under the national protocol in Senegal, and the secondary outcomes were weight gain, referral to inpatient care, enteric pathogen detection, diarrhoea, and all-cause mortality. Participants were followed up over eight weeks. Findings: Between 22 December 2021 and 20 February 2023, 2,411 children were enrolled in the study with 777 defaulting outpatient treatment during eight weeks’ follow-up. There was no difference between control and intervention groups in the proportion of children recovering from SAM eight weeks post admission (39.8% vs 41.2%; adjusted odds ratio [aOR]: 0.97, 95% Confidence Interval [CI]: 0.66, 1.48). There was no difference in weight gain, referral, enteric pathogen detection or mortality between groups. The prevalence of diarrhoea at eight weeks follow-up was higher in the control group (20.0%) than the intervention group (12.5%), with evidence for a large difference between arms, accounting for between-group differences at baseline (aOR: 0.36; 95%CI: 0.26, 0.50). Interpretation: The integration of household water treatment and hygiene promotion in the standard national protocol did not improve SAM recovery nor the related outcomes of weight gain, referral, enteric pathogen detection or mortality but did reduce diarrhoea. Our results suggest that the integration of this intervention to the standard protocol would not improve SAM outcomes in this setting but would potentially reduce the burden of diarrhoea among this vulnerable group. Funding: This study was supported by the Bureau of Humanitarian Assistance of the United States Agency for International Development and the ACF Foundation.
Open AccessEffect of household water treatment and hygiene promotion integration on outpatient treatment for severe acute malnutrition in Senegal: the TISA cluster-randomised controlled trial
Background: Severe acute malnutrition (SAM) affects approximately 12 million children globally. The aim of this study was to assess the effectiveness of integrating a household water treatment and hygiene promotion intervention within the national protocol of Senegal for outpatient treatment of children aged 6-59 months of age with uncomplicated SAM. Methods: This was a pragmatic cluster-randomised controlled trial with health centres allocated 1:1 to receive either the standard protocol alone or the standard protocol with the addition of the water treatment and hygiene intervention. The primary outcome of the trial was SAM recovery defined under the national protocol in Senegal, and the secondary outcomes were weight gain, referral to inpatient care, enteric pathogen detection, diarrhoea, and all-cause mortality. Participants were followed up over eight weeks. Findings: Between 22 December 2021 and 20 February 2023, 2,411 children were enrolled in the study with 777 defaulting outpatient treatment during eight weeks’ follow-up. There was no difference between control and intervention groups in the proportion of children recovering from SAM eight weeks post admission (39.8% vs 41.2%; adjusted odds ratio [aOR]: 0.97, 95% Confidence Interval [CI]: 0.66, 1.48). There was no difference in weight gain, referral, enteric pathogen detection or mortality between groups. The prevalence of diarrhoea at eight weeks follow-up was higher in the control group (20.0%) than the intervention group (12.5%), with evidence for a large difference between arms, accounting for between-group differences at baseline (aOR: 0.36; 95%CI: 0.26, 0.50). Interpretation: The integration of household water treatment and hygiene promotion in the standard national protocol did not improve SAM recovery nor the related outcomes of weight gain, referral, enteric pathogen detection or mortality but did reduce diarrhoea. Our results suggest that the integration of this intervention to the standard protocol would not improve SAM outcomes in this setting but would potentially reduce the burden of diarrhoea among this vulnerable group. Funding: This study was supported by the Bureau of Humanitarian Assistance of the United States Agency for International Development and the ACF Foundation.
- Open Access
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (7) , e0005497
Hazard analysis and critical control points for foods consumed by children aged 6–24 months in Maputo, Mozambique
Diarrhoeal disease remains a significant cause of mortality among children under five, particularly in high-burden settings where food consumed by young children is frequently contaminated. Understanding food preparation, feeding, and storage practices for children aged 6–24 months is essential to inform interventions that reduce diarrhoeal disease. Using the Hazard Analysis and Critical Control Points (HACCP) approach, we identified critical control points (CCPs) associated with potential food contamination among households with a child aged 6–24 months in the Polana Caniço neighbourhood of Maputo, Mozambique. We conducted 110 structured observations of household food hygiene practices, including food handling, preparation, cooking, feeding, and storage, to identify key hazards and CCPs for microbial contamination of foods consumed by young children. Food flow diagrams were developed for the main food groups to support the HACCP analysis. Our systematic assessment of food hygiene behaviours identified several key practices to target: cleaning utensils used for child feeding, caregiver handwashing with soap before feeding, boiling liquids added to food, storing cooked food in clean containers, and thoroughly cooking and reheating food before feeding. While these CCPs are consistent with those identified in similar settings, our findings provide context-specific evidence on food hygiene practices in an urban informal setting. These findings can inform future research to evaluate the relative importance of identified hazards and CCPs and guide policymakers and practitioners in designing household- and community-level interventions to reduce foodborne health risks among young children.
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (7) , e0005497
Open AccessHazard analysis and critical control points for foods consumed by children aged 6–24 months in Maputo, Mozambique
Diarrhoeal disease remains a significant cause of mortality among children under five, particularly in high-burden settings where food consumed by young children is frequently contaminated. Understanding food preparation, feeding, and storage practices for children aged 6–24 months is essential to inform interventions that reduce diarrhoeal disease. Using the Hazard Analysis and Critical Control Points (HACCP) approach, we identified critical control points (CCPs) associated with potential food contamination among households with a child aged 6–24 months in the Polana Caniço neighbourhood of Maputo, Mozambique. We conducted 110 structured observations of household food hygiene practices, including food handling, preparation, cooking, feeding, and storage, to identify key hazards and CCPs for microbial contamination of foods consumed by young children. Food flow diagrams were developed for the main food groups to support the HACCP analysis. Our systematic assessment of food hygiene behaviours identified several key practices to target: cleaning utensils used for child feeding, caregiver handwashing with soap before feeding, boiling liquids added to food, storing cooked food in clean containers, and thoroughly cooking and reheating food before feeding. While these CCPs are consistent with those identified in similar settings, our findings provide context-specific evidence on food hygiene practices in an urban informal setting. These findings can inform future research to evaluate the relative importance of identified hazards and CCPs and guide policymakers and practitioners in designing household- and community-level interventions to reduce foodborne health risks among young children.
- Open Access
Microbiological Quality of Weaning Foods and Hygiene-Related Risk Factors in Peri-Urban, Lusaka Zambia
Food contamination contributes to 40% of childhood diarrhoea cases globally. It occurs when pathogens are transmitted from faecal matter to food through the faecal oral route. Food hygiene can prevent food contamination and improve the microbial quality of weaning foods in domestic settings. However, context specific evidence is needed to identify risk factors associated with food contamination, especially in complex low-income communities. Our study used a modified Hazard Analysis Critical Control Point approach to assess the quality of weaning foods and identify associated risk factors in a low income setting of Lusaka, Zambia. We enrolled 60 caregivers of children aged < 1 year who had begun complementary feeding and collected data on household characteristics and food hygiene behaviours using surveys and structured observations. We collected samples of complimentary foods prepared for the child and tested them for Escherichia coli (E. coli) using the IDEXX Colilert-18 method. Multivariable logistic regression was performed to determine risk factors associated with food contamination. Of 59 food samples, 17 (29%) were contaminated with E. coli . Porridge (AOR = 0.04; 95% CI: 0.01, 0.28; p = 0.001) and non-animal source foods (AOR = 0.11; 95% CI: 0.02, 0.69; p = 0.019) were associated with lower odds of contamination compared with animal source foods. Heating of food was also associated with lower odds of contamination but was not significant. Food hygiene behaviours including utensil and surface cleaning were seldom practiced (17% and 15%, respectively), and handwashing with soap before food preparation was not practiced. Our study identifies the microbiological risk associated with animal source foods and the potential health risk posed to weaning children. Nutrition guidelines should take into consideration this risk as programs promote an increased uptake of animal source foods in child diets.
Open AccessMicrobiological Quality of Weaning Foods and Hygiene-Related Risk Factors in Peri-Urban, Lusaka Zambia
Food contamination contributes to 40% of childhood diarrhoea cases globally. It occurs when pathogens are transmitted from faecal matter to food through the faecal oral route. Food hygiene can prevent food contamination and improve the microbial quality of weaning foods in domestic settings. However, context specific evidence is needed to identify risk factors associated with food contamination, especially in complex low-income communities. Our study used a modified Hazard Analysis Critical Control Point approach to assess the quality of weaning foods and identify associated risk factors in a low income setting of Lusaka, Zambia. We enrolled 60 caregivers of children aged < 1 year who had begun complementary feeding and collected data on household characteristics and food hygiene behaviours using surveys and structured observations. We collected samples of complimentary foods prepared for the child and tested them for Escherichia coli (E. coli) using the IDEXX Colilert-18 method. Multivariable logistic regression was performed to determine risk factors associated with food contamination. Of 59 food samples, 17 (29%) were contaminated with E. coli . Porridge (AOR = 0.04; 95% CI: 0.01, 0.28; p = 0.001) and non-animal source foods (AOR = 0.11; 95% CI: 0.02, 0.69; p = 0.019) were associated with lower odds of contamination compared with animal source foods. Heating of food was also associated with lower odds of contamination but was not significant. Food hygiene behaviours including utensil and surface cleaning were seldom practiced (17% and 15%, respectively), and handwashing with soap before food preparation was not practiced. Our study identifies the microbiological risk associated with animal source foods and the potential health risk posed to weaning children. Nutrition guidelines should take into consideration this risk as programs promote an increased uptake of animal source foods in child diets.
- Open Access
- 2 June 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (6) , e0358725
Gut microbiome associations with acute malnutrition relapse in South Sudan
Severe acute malnutrition (SAM) is a leading cause of childhood morbidity and mortality that is defined by anthropometric measurements, weight-for-height z score, and mid-upper arm circumference (MUAC) falling significantly below healthy standards. While treatments for SAM and our understanding of this disease have advanced, children experiencing SAM frequently relapse to acute malnutrition (AM) following anthropometric recovery. Little is known about the contribution of the gut microbiome to AM relapse. We hypothesized that features of the gut microbiome, including microbial composition, antimicrobial resistance gene carriage, and predicted microbial functional pathways, of children discharged from treatment for uncomplicated SAM in South Sudan, may be associated with AM relapse at 1-month follow-up. Overall, broad microbiome profiles at discharge were not associated with AM relapse. We evaluated the associations of microbiome features with AM relapse 1-month post-recovery using mixed linear effect models. We identified associations between higher MUAC, which may be a proxy for future health trajectories, and increased Sutterella wadsworthensis and trimethoprim-resistant dihydrofolate reductase antimicrobial resistance genes. These findings suggest that the gut microbiome at discharge of children treated for uncomplicated SAM has limited predictive value as a standalone diagnostic tool for identifying relapse risk at 1 month. IMPORTANCE: Severe acute malnutrition (SAM) is a devastating illness that impacts the morbidity and mortality of millions of children worldwide. Community-based management of acute malnutrition (CMAM) is the standard of care in South Sudan and many other low-resource settings for children presenting with SAM. Despite this intervention, children treated for SAM under CMAM frequently relapse to acute malnutrition (AM) following treatment. With advancements in our understanding of malnutrition, there has been a strong and growing interest in developing microbiome-based strategies to treat, prevent, and predict relapse to AM following treatment for SAM. Our work characterizes gut microbiome features of children from a geographic area that is traditionally underrepresented in gut microbiome research and shows that in isolation, a child’s gut microbiome at discharge likely holds low predictive value for relapse to AM post-CMAM treatment; however, we identified key microbes and microbial features meriting further research.
- 2 June 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (6) , e0358725
Open AccessGut microbiome associations with acute malnutrition relapse in South Sudan
Severe acute malnutrition (SAM) is a leading cause of childhood morbidity and mortality that is defined by anthropometric measurements, weight-for-height z score, and mid-upper arm circumference (MUAC) falling significantly below healthy standards. While treatments for SAM and our understanding of this disease have advanced, children experiencing SAM frequently relapse to acute malnutrition (AM) following anthropometric recovery. Little is known about the contribution of the gut microbiome to AM relapse. We hypothesized that features of the gut microbiome, including microbial composition, antimicrobial resistance gene carriage, and predicted microbial functional pathways, of children discharged from treatment for uncomplicated SAM in South Sudan, may be associated with AM relapse at 1-month follow-up. Overall, broad microbiome profiles at discharge were not associated with AM relapse. We evaluated the associations of microbiome features with AM relapse 1-month post-recovery using mixed linear effect models. We identified associations between higher MUAC, which may be a proxy for future health trajectories, and increased Sutterella wadsworthensis and trimethoprim-resistant dihydrofolate reductase antimicrobial resistance genes. These findings suggest that the gut microbiome at discharge of children treated for uncomplicated SAM has limited predictive value as a standalone diagnostic tool for identifying relapse risk at 1 month. IMPORTANCE: Severe acute malnutrition (SAM) is a devastating illness that impacts the morbidity and mortality of millions of children worldwide. Community-based management of acute malnutrition (CMAM) is the standard of care in South Sudan and many other low-resource settings for children presenting with SAM. Despite this intervention, children treated for SAM under CMAM frequently relapse to acute malnutrition (AM) following treatment. With advancements in our understanding of malnutrition, there has been a strong and growing interest in developing microbiome-based strategies to treat, prevent, and predict relapse to AM following treatment for SAM. Our work characterizes gut microbiome features of children from a geographic area that is traditionally underrepresented in gut microbiome research and shows that in isolation, a child’s gut microbiome at discharge likely holds low predictive value for relapse to AM post-CMAM treatment; however, we identified key microbes and microbial features meriting further research.
- Open Access
intI1 predicts ARGs and human source tracking markers carried by coprophagous flies in Maputo, Mozambique
Wastewater surveillance is increasingly used for antimicrobial resistance (AMR) monitoring in urban environments, but low-resource settings often lack a piped sewerage system. Instead, coprophagous flies—flies that ingest feces—may serve as composite samplers for monitoring fecal wastes present in terrestrial environments. We evaluated whether the class 1 integron-integrase gene intI1 was associated with genetic markers of AMR and fecal source tracking markers (FST) in coprophagous flies collected from latrine entrances and food preparation areas in low-income urban Maputo, Mozambique. We quantified intI1 , an enteric 16S rRNA target (for normalization), three FST markers, and 30 ARG targets using qPCR. We normalized concentrations of intI1 and each target to enteric 16S rRNA. We fit linear mixed models with a random intercept for housing compound to estimate within-fly associations between log 10 relative abundance of intI1 and log 10 relative abundance of each target with and without adjustment for fly taxonomic group, capture location, and standardized fly mass. We also modeled per-fly unique ARG count (i.e., number of ARG targets detected) using Poisson regression. Of 188 flies assayed, 176 passed internal controls; intI1 and enteric 16S rRNA were detected in 95% and 96% of flies, respectively. Higher relative abundance of intI1 was positively associated with ARG and FST targets, with the strongest associations observed for sulfonamide-( sul1 : β = 0.87; 95% CI: 0.81, 0.94; sul2 : β = 0.81; 95% CI: 0.73, 0.89), tetracycline- ( tetA : β = 0.78; 95% CI: 0.70, 0.85; tetB : β = 0.69; 95% CI: 0.60, 0.79), and trimethoprim-related ( dfrA17 : β = 0.78; 95% CI: 0.70, 0.86) genes. Associations with FST markers were weaker (i.e., human mtDNA: β = 0.46; 95% CI: 0.37, 0.55; human-associated Bacteroides : β = 0.34; 95% CI: 0.25, 0.43). Higher relative abundance of intI1 was also associated with a greater number of ARGs detected: each 10-fold increase in intI1 was associated with an 8% higher expected unique ARG count (aRR=1.08, 95% CI: 1.04–1.12). These findings support the need for further research across different settings exploring intI1 carried by coprophagous flies as a potential standardized screening target for AMR surveillance in unsewered terrestrial environments.
Open AccessintI1 predicts ARGs and human source tracking markers carried by coprophagous flies in Maputo, Mozambique
Wastewater surveillance is increasingly used for antimicrobial resistance (AMR) monitoring in urban environments, but low-resource settings often lack a piped sewerage system. Instead, coprophagous flies—flies that ingest feces—may serve as composite samplers for monitoring fecal wastes present in terrestrial environments. We evaluated whether the class 1 integron-integrase gene intI1 was associated with genetic markers of AMR and fecal source tracking markers (FST) in coprophagous flies collected from latrine entrances and food preparation areas in low-income urban Maputo, Mozambique. We quantified intI1 , an enteric 16S rRNA target (for normalization), three FST markers, and 30 ARG targets using qPCR. We normalized concentrations of intI1 and each target to enteric 16S rRNA. We fit linear mixed models with a random intercept for housing compound to estimate within-fly associations between log 10 relative abundance of intI1 and log 10 relative abundance of each target with and without adjustment for fly taxonomic group, capture location, and standardized fly mass. We also modeled per-fly unique ARG count (i.e., number of ARG targets detected) using Poisson regression. Of 188 flies assayed, 176 passed internal controls; intI1 and enteric 16S rRNA were detected in 95% and 96% of flies, respectively. Higher relative abundance of intI1 was positively associated with ARG and FST targets, with the strongest associations observed for sulfonamide-( sul1 : β = 0.87; 95% CI: 0.81, 0.94; sul2 : β = 0.81; 95% CI: 0.73, 0.89), tetracycline- ( tetA : β = 0.78; 95% CI: 0.70, 0.85; tetB : β = 0.69; 95% CI: 0.60, 0.79), and trimethoprim-related ( dfrA17 : β = 0.78; 95% CI: 0.70, 0.86) genes. Associations with FST markers were weaker (i.e., human mtDNA: β = 0.46; 95% CI: 0.37, 0.55; human-associated Bacteroides : β = 0.34; 95% CI: 0.25, 0.43). Higher relative abundance of intI1 was also associated with a greater number of ARGs detected: each 10-fold increase in intI1 was associated with an 8% higher expected unique ARG count (aRR=1.08, 95% CI: 1.04–1.12). These findings support the need for further research across different settings exploring intI1 carried by coprophagous flies as a potential standardized screening target for AMR surveillance in unsewered terrestrial environments.
- Open Access
Effect of a sanitation intervention on the nutritional status of children in Maputo, Mozambique: a controlled before-and-after trial
Background The rapid growth of the global urban population has contributed to the expansion of informal urban settlements in many cities across the world. In these settings, lack of safe sanitation combined with high population density and poverty contributes to heightened health risks for often vulnerable populations. The aim of this study was to evaluate the effect of a shared, onsite sanitation intervention on the nutritional status of children in Maputo, Mozambique. Methods The Maputo Sanitation (MapSan) trial was a controlled before and after study to evaluate the effect of a shared, onsite sanitation intervention on child health in Maputo, Mozambique. Here, we report the effects on childhood stunting, wasting and underweight, and height for age, weight for height and weight for age z scores. Children were enrolled aged 1 to 48 months at baseline and outcomes were measured before and 12 and 24 months after the intervention, with concurrent measurement among children in a comparable control arm. The primary analysis was intention to treat. The trial was registered at ClinicalTrials.gov, number NCT02362932 . Results We enrolled 757 and 852 children in the intervention and control groups respectively. There was no evidence for an effect of the intervention on any outcome at 12 or 24 months of follow-up except for wasting where there was very weak evidence for an effect (adjusted prevalence ratio: 0.497; 95% CI: 0.22, 1.11; p value 0.09). In two exploratory analyses, one including only those children born into compounds post intervention and a second excluding children in control compounds which had independently improved their sanitation facilities during follow-up, we found that stunting increased in the intervention group whilst wasting decreased. Conclusions This study contributes to the growing evidence on the role of sanitation in shaping child health outcomes in informal urban settlements. We found no evidence for an effect on stunting and weak evidence for an effect on wasting. More research is needed to understand how sanitation can reduce childhood undernutrition in complex urban environments.
Open AccessEffect of a sanitation intervention on the nutritional status of children in Maputo, Mozambique: a controlled before-and-after trial
Background The rapid growth of the global urban population has contributed to the expansion of informal urban settlements in many cities across the world. In these settings, lack of safe sanitation combined with high population density and poverty contributes to heightened health risks for often vulnerable populations. The aim of this study was to evaluate the effect of a shared, onsite sanitation intervention on the nutritional status of children in Maputo, Mozambique. Methods The Maputo Sanitation (MapSan) trial was a controlled before and after study to evaluate the effect of a shared, onsite sanitation intervention on child health in Maputo, Mozambique. Here, we report the effects on childhood stunting, wasting and underweight, and height for age, weight for height and weight for age z scores. Children were enrolled aged 1 to 48 months at baseline and outcomes were measured before and 12 and 24 months after the intervention, with concurrent measurement among children in a comparable control arm. The primary analysis was intention to treat. The trial was registered at ClinicalTrials.gov, number NCT02362932 . Results We enrolled 757 and 852 children in the intervention and control groups respectively. There was no evidence for an effect of the intervention on any outcome at 12 or 24 months of follow-up except for wasting where there was very weak evidence for an effect (adjusted prevalence ratio: 0.497; 95% CI: 0.22, 1.11; p value 0.09). In two exploratory analyses, one including only those children born into compounds post intervention and a second excluding children in control compounds which had independently improved their sanitation facilities during follow-up, we found that stunting increased in the intervention group whilst wasting decreased. Conclusions This study contributes to the growing evidence on the role of sanitation in shaping child health outcomes in informal urban settlements. We found no evidence for an effect on stunting and weak evidence for an effect on wasting. More research is needed to understand how sanitation can reduce childhood undernutrition in complex urban environments.
- 1 February 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (2) , 207-215
The Incubation Periods of Mpox Virus Clade Ib
Mpox virus (MPXV) clade Ib, first detected in the Democratic Republic of the Congo (DRC) in September 2023, spread internationally within months, prompting an emergency declaration from the World Health Organization. Data on its incubation period, which both shapes outbreak dynamics and informs epidemic response strategies, remain limited. To estimate the incubation periods of mpox clade Ib, examining evidence for differences by route of exposure and demographic factors. Bayesian analysis of clinical surveillance data collected between June and October 2024. South Kivu, DRC, the epicenter of the current mpox clade Ib global outbreak. Clinically attended persons with confirmed mpox clade Ib infection. Demographic characteristics, exposure history, symptom onset, and transmission route. Among 37 polymerase chain reaction-confirmed cases with high viral load (cycle threshold values <34), the median incubation period from exposure to rash was 13.6 days (95% credible interval [CrI], 9.6 to 19.0 days). Five percent of cases are expected to develop a rash within 3.1 days (CrI, 1.3 to 5.5 days) and 95% within 32.3 days (CrI, 22.4 to 45.8 days). The incubation period seemed to differ by putative transmission route: Sexual transmission had a shorter median (10.3 days [CrI, 3.1 to 20.3 days]) than nonsexual transmission (13.5 days [CrI, 9.5 to 19.1 days]), although the CrIs overlapped. Surveillance data lacked detailed exposure histories and a lower bound for exposure periods, but models accounted for these uncertainties, yielding robust median estimates. Evidence from this study suggests that clade Ib may have a longer incubation period than other MPXV clades, and this may vary by transmission route. The shorter incubation for sexual transmission mirrors patterns seen in the predominantly sexually transmitted clade IIb outbreak, highlighting the potential role of exposure route in disease progression. These findings have implications for global recommendations on postexposure monitoring periods and prophylaxis. Gates Foundation and Geneva Centre for Emerging Viral Diseases.
- 1 February 2026
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (2) , 207-215
The Incubation Periods of Mpox Virus Clade Ib
Mpox virus (MPXV) clade Ib, first detected in the Democratic Republic of the Congo (DRC) in September 2023, spread internationally within months, prompting an emergency declaration from the World Health Organization. Data on its incubation period, which both shapes outbreak dynamics and informs epidemic response strategies, remain limited. To estimate the incubation periods of mpox clade Ib, examining evidence for differences by route of exposure and demographic factors. Bayesian analysis of clinical surveillance data collected between June and October 2024. South Kivu, DRC, the epicenter of the current mpox clade Ib global outbreak. Clinically attended persons with confirmed mpox clade Ib infection. Demographic characteristics, exposure history, symptom onset, and transmission route. Among 37 polymerase chain reaction-confirmed cases with high viral load (cycle threshold values <34), the median incubation period from exposure to rash was 13.6 days (95% credible interval [CrI], 9.6 to 19.0 days). Five percent of cases are expected to develop a rash within 3.1 days (CrI, 1.3 to 5.5 days) and 95% within 32.3 days (CrI, 22.4 to 45.8 days). The incubation period seemed to differ by putative transmission route: Sexual transmission had a shorter median (10.3 days [CrI, 3.1 to 20.3 days]) than nonsexual transmission (13.5 days [CrI, 9.5 to 19.1 days]), although the CrIs overlapped. Surveillance data lacked detailed exposure histories and a lower bound for exposure periods, but models accounted for these uncertainties, yielding robust median estimates. Evidence from this study suggests that clade Ib may have a longer incubation period than other MPXV clades, and this may vary by transmission route. The shorter incubation for sexual transmission mirrors patterns seen in the predominantly sexually transmitted clade IIb outbreak, highlighting the potential role of exposure route in disease progression. These findings have implications for global recommendations on postexposure monitoring periods and prophylaxis. Gates Foundation and Geneva Centre for Emerging Viral Diseases.
- Open Access
- 18 December 2025
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 30 (50)
Community transmission of mpox clade Ib not driven through sexual exposures, Uvira, eastern Democratic Republic of the Congo, June to October 2024
BACKGROUND: In September 2023, monkeypox virus (MPXV) clade Ib emerged in Kamituga, a mining zone in South Kivu, Democratic Republic of the Congo (DRC), primarily through sexual transmission. AIM: We aimed to investigate cases in a MPXV clade Ib outbreak in Uvira, eastern DRC. METHODS: From June to October 2024, we collected demographic, exposure and clinical data from suspected mpox cases at Uvira hospital and in households. The virus was identified by PCR. We investigated putative transmission patterns, disease severity and risk factors. RESULTS: We identified 973 suspected cases: 415 (42.7%) were tested with PCR and 322 (77.6%) were confirmed. The median age of suspected cases was 9 years (interquartile range (IQR): 3–20 years), with 620 (63.7%) aged < 15 and 344 (35.4%) < 5 years. Severe disease (≥ 100 lesions) was more common in cases aged < 15 years (25.6%; 142/554) than others (16.1%; 49/304; p < 0.001). Twenty-two (12.2%) of 181 cases aged < 5 years had acute malnutrition. Seven cases died; the overall case-fatality ratio was 0.7%, and in infants (aged < 1 year) it was 3.9% (5/127). Of 329 suspected cases tested for HIV, six (1.8%) were positive. Nineteen (14.5%) of 131 females aged 15–49 years were pregnant. Most reported exposures to suspected mpox cases occurred in households (67.9%; 298/439). Sexual (6.0%; 19/318) or healthcare-related occupational exposures (1.4%; 6/417) were less common. Animal exposures were few (5.0%; 39/776) and predominantly domestic (97.4%; 38/39). CONCLUSION: This child-centred outbreak, driven by non-sexual transmission, underscores the need for paediatric vaccines, nutritional support and household interventions. Adult-focused responses alone may be insufficient to control the outbreak.
- 18 December 2025
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 30 (50)
Open AccessCommunity transmission of mpox clade Ib not driven through sexual exposures, Uvira, eastern Democratic Republic of the Congo, June to October 2024
BACKGROUND: In September 2023, monkeypox virus (MPXV) clade Ib emerged in Kamituga, a mining zone in South Kivu, Democratic Republic of the Congo (DRC), primarily through sexual transmission. AIM: We aimed to investigate cases in a MPXV clade Ib outbreak in Uvira, eastern DRC. METHODS: From June to October 2024, we collected demographic, exposure and clinical data from suspected mpox cases at Uvira hospital and in households. The virus was identified by PCR. We investigated putative transmission patterns, disease severity and risk factors. RESULTS: We identified 973 suspected cases: 415 (42.7%) were tested with PCR and 322 (77.6%) were confirmed. The median age of suspected cases was 9 years (interquartile range (IQR): 3–20 years), with 620 (63.7%) aged < 15 and 344 (35.4%) < 5 years. Severe disease (≥ 100 lesions) was more common in cases aged < 15 years (25.6%; 142/554) than others (16.1%; 49/304; p < 0.001). Twenty-two (12.2%) of 181 cases aged < 5 years had acute malnutrition. Seven cases died; the overall case-fatality ratio was 0.7%, and in infants (aged < 1 year) it was 3.9% (5/127). Of 329 suspected cases tested for HIV, six (1.8%) were positive. Nineteen (14.5%) of 131 females aged 15–49 years were pregnant. Most reported exposures to suspected mpox cases occurred in households (67.9%; 298/439). Sexual (6.0%; 19/318) or healthcare-related occupational exposures (1.4%; 6/417) were less common. Animal exposures were few (5.0%; 39/776) and predominantly domestic (97.4%; 38/39). CONCLUSION: This child-centred outbreak, driven by non-sexual transmission, underscores the need for paediatric vaccines, nutritional support and household interventions. Adult-focused responses alone may be insufficient to control the outbreak.